Skip to content
Sign In

Main Navigation

James Sharp Logo
  • Individuals
    Individuals

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service

    Investing

    • Inheritance TaxInheritance Tax
  • Charities & Trustees
    Charities & Trustees

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service

  • Companies
    Companies

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service

  • News & Insights
    • News & Insights
    • Current Research Coverage List
  • About Us
    • About Us
    • Our People
  • Conectus Portal
  • Contact Us

Market News - Page 466

4 February 2021

Cranswick PLC Third Quarter Trading Statement 2021

Cranswick today provides an update on trading for the 13 weeks to 26 December 2020….

4 February 2021

Renishaw PLC Interim Report 2021

Renishaw today reports its half-year results for the six months to 31 December 2020….

4 February 2021

BT Group PLC Trading Update Ended 31st December 2020

BT Group plc (BT.L) today announced its trading update for the nine months to 31 December 2020….

4 February 2021

Severn Trent PLC Trading Statement: 1st October 2020- 4th February 2021

Severn Trent Plc today announces a trading update for the period to 4 February 2021….

4 February 2021

Unilever PLC 2020 Full Year Results

Performance highlights (unaudited) Underlying performance GAAP measures     vs 2019     vs 2019 Full Year           Underlying sales growth…

4 February 2021

Barrat Developments PLC Half Year Results 2020

Half year results for the six month period ended 31 December 2020….

3 February 2021

Vodafone PLC: Q3 FY21 Trading Update

Vodafone announces its Q3 performance ended 31st December 2020….

3 February 2021

GlaxoSmithKline PLC- GSK/CureVac Partner on New mRNA Covid-19 Vaccines

GSK and CureVac to develop next generation mRNA COVID-19 vaccines. Development to begin immediately targeting vaccine availability in 2022, subject to regulatory approval. GSK will also support manufacture of up to 100 million doses of CureVac's first generation COVID-19 vaccine CVnCoV in 2021….

Posts navigation

  • «
  • 1
  • …
  • 464
  • 465
  • 466
  • 467
  • 468
  • …
  • 874
  • »

Home > Market News > Page 466

James Sharp white Logo
Sign In
Linkedin Icon

The Exchange
5 Bank Street
Bury, Lancashire
BL9 0DN

Tel: 0161 764 4043

Fax: 0161 764 1628

Email: mail@jamessharp.dev.icgonline.co.uk

Linkedin Icon

James Sharp & Co is a trading name
of James Sharp & Co LLP (0C422665)

Members of the LLP are referred to as Partners

  • Downloads & Resources
  • Complaints
  • Financial Compensation Scheme
  • Conectus Portal

  • Cyber Essentials Certification
  • Website Terms & Conditions
  • Privacy Policy
  • Cookie policy
  • Consent Preferences

Email Newsletter Sign-up

Consent(Required)
What we do with you information. Find out more
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© Copyright 2010-2026. All rights reserved. James Sharp & Co. Authorised & Regulated by the Financial Conduct Authority
Member of the London Stock Exchange - Member of the Aquis Stock Exchange - Member of PIMFA

Website by ICG